Skip to search.
 TSX Up 0.40% TSX Ventures Down 1.68%

Geron Corporation (GERN)

-NasdaqGS
2.85 Up 0.04(1.42%) May 27, 4:00PM EDT
Prev Close:2.81
Open:2.82
Bid:2.72 x 500
Ask:2.96 x 3500
1y Target Est:7.50
Beta:2.99212
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:2.75 - 2.85
52wk Range:2.30 - 5.30
Volume:1,073,420
Avg Vol (3m):2,184,090
Market Cap:453.04M
P/E (ttm):950.00
EPS (ttm):0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 1.42%453.04M
BMYUp 0.82%119.04B
GSKDown 0.79%103.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.26
Quarterly EPS Est (Jun-16) :-0.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-2.16

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback